News

From raised melanoma-risk in childhood to exacerbating autoimmune symptoms in adulthood, overexposure to the sun carries ...
Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.